JAK2, STAT3, and STAT5 knockdown resulted in a significant decrease of colony-forming cells, cell numbers, and survival, while this was not observed with downregulation of JAK1, indicating that inhibition of JAK2 is more effective in decreasing growth and survival of AML CD34+ cells than inhibition of JAK1. The gene discussed is STAT3; the disease is acute myeloid leukemia.